187 related articles for article (PubMed ID: 31820300)
1. Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide.
Bhalerao H; Koteshwara KB; Chandran S
Drug Deliv Transl Res; 2020 Apr; 10(2):529-547. PubMed ID: 31820300
[TBL] [Abstract][Full Text] [Related]
2. Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation.
Bhalerao H; Koteshwara KB; Chandran S
AAPS PharmSciTech; 2020 Jan; 21(2):69. PubMed ID: 31950311
[TBL] [Abstract][Full Text] [Related]
3. A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation.
Sun J; Zhou Z
Drug Des Devel Ther; 2018; 12():383-389. PubMed ID: 29503531
[TBL] [Abstract][Full Text] [Related]
4. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
[TBL] [Abstract][Full Text] [Related]
5. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide.
Morsi N; Ibrahim M; Refai H; El Sorogy H
Eur J Pharm Sci; 2017 Jun; 104():302-314. PubMed ID: 28433750
[TBL] [Abstract][Full Text] [Related]
6. Levofloxacin Hemihydrate In Situ Gelling Ophthalmic Solution: Formulation Optimization and In Vitro and In Vivo Evaluation.
Bhalerao H; Koteshwara KB; Chandran S
AAPS PharmSciTech; 2019 Aug; 20(7):272. PubMed ID: 31372767
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of a brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery.
Li J; Liu H; Liu LL; Cai CN; Xin HX; Liu W
Chem Pharm Bull (Tokyo); 2014; 62(10):1000-8. PubMed ID: 25099146
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Holló G; Kóthy P
Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
[TBL] [Abstract][Full Text] [Related]
9. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma.
Salama HA; Ghorab M; Mahmoud AA; Abdel Hady M
AAPS PharmSciTech; 2017 Oct; 18(7):2517-2528. PubMed ID: 28224390
[TBL] [Abstract][Full Text] [Related]
10. TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma.
Jin Q; Li H; Jin Z; Huang L; Wang F; Zhou Y; Liu Y; Jiang C; Oswald J; Wu J; Song X
Int J Pharm; 2018 Dec; 553(1-2):21-28. PubMed ID: 30316795
[TBL] [Abstract][Full Text] [Related]
11. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
Dubey V; Mohan P; Dangi JS; Kesavan K
Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation.
Wu W; Li J; Wu L; Wang B; Wang Z; Xu Q; Xin H
AAPS PharmSciTech; 2013 Sep; 14(3):1063-71. PubMed ID: 23813437
[TBL] [Abstract][Full Text] [Related]
13. Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
Bhagav P; Upadhyay H; Chandran S
AAPS PharmSciTech; 2011 Dec; 12(4):1087-101. PubMed ID: 21879393
[TBL] [Abstract][Full Text] [Related]
14. Dose-response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide Dose-Response Study Group.
Silver LH
Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S147-53. PubMed ID: 10665517
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy.
Li T; Wang Y; Chen J; Gao X; Pan S; Su Y; Zhou X
Drug Deliv; 2020 Dec; 27(1):410-421. PubMed ID: 32133894
[TBL] [Abstract][Full Text] [Related]
16. Impact of Ocular Compatible Lipoids and Castor Oil in Fabrication of Brimonidine Tartrate Nanoemulsions by 3
Rimple ; Newton MJ
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):169-183. PubMed ID: 30058499
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: a randomized clinical trial.
Whitson JT; Roarty JD; Vijaya L; Robin AL; Gross RD; Landry TA; Dickerson JE; Scheib SA; Scott H; Hua SY; Woodside AM; Bergamini MV;
J AAPOS; 2008 Jun; 12(3):239-246.e3. PubMed ID: 18289898
[TBL] [Abstract][Full Text] [Related]
18. [Clinical investigation: the intraocular pressure-lowering efficacy and safety of brinzolamide combined with betaxolol].
Minbin Y; Fang M; Ge J; Huang S
Yan Ke Xue Bao; 2005 Dec; 21(4):137-40, 152. PubMed ID: 17162869
[TBL] [Abstract][Full Text] [Related]
19. Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.
Day DG; Hollander DA
Curr Med Res Opin; 2008 May; 24(5):1435-42. PubMed ID: 18402717
[TBL] [Abstract][Full Text] [Related]
20. Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma.
Januleviciene I
Curr Med Res Opin; 2010 Nov; 26(11):2575-8. PubMed ID: 20868340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
